Global Antibiotic R&D Partnership (GARDP)
Alison Luckey FFPM is a seasoned medical professional with extensive experience in antibiotic research and development. Currently serving as Senior Medical Lead at the Global Antibiotic R&D Partnership (GARDP) since September 2021, Alison has previously held significant roles at Pfizer Global Product Development as Snr Director MD/Internal Medicine and Hospital - Anti-Infectives, and at Pfizer Essential Health as Director Physician. Additional experience includes directorial positions at AstraZeneca Global Medical and Astellas Pharma Europe, alongside clinical roles at Lipid & Diabetes Research Group and Primorus Clinical Trials. Alison began a medical career as Medical Advisor Cardiovascular at Solvay Healthcare Ltd, bringing a wealth of expertise in clinical research and medical leadership across various pharmaceutical sectors.
This person is not in any offices
Global Antibiotic R&D Partnership (GARDP)
The Global Antibiotic Research & Development Partnership (GARDP) is a not-for-profit organization that develops new antibiotic treatments for drug-resistant bacterial infections that pose the greatest threat to human health, and makes them accessible to the people who need them. It puts public health needs at the centre of antibiotic drug development to address both the immediate antimicrobial resistance (AMR) crisis and to ensure people continue to get access to essential antibiotics for generations to come. GARDP works through a global network including Brazil, India, Japan, and South Africa for antibiotic development and access. Its work is made possible by essential funding from donors and collaboration with over 100 R&D and access partners in over 20 countries. GARDP was created by the World Health Organization and the Drugs for Neglected Diseases initiative (DNDi) in 2016 and legally registered as the GARDP Foundation in Geneva, Switzerland in 2018. www.gardp.org